Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

A man with X-ALD improved after treatment, highlighting the need to consider X-ALD in similar patients and test their relatives.

A woman lost all her body hair after hepatitis C treatment, but it started to grow back a year after stopping the treatment.

Thorough scalp examination is crucial for diagnosing alopecia areata incognita in men with diffuse hair loss.

The ABHRS exam will be available online in 2021.

Afatinib often causes skin problems that need proactive management.

ASLNC168501 can help treat hair loss by restoring hair follicle stem cell function.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

A new mouse mutation causes skin and hair defects due to a gene change.

The modified staining method can determine the ABO blood group of hair samples accurately.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Skin issues and diarrhea can signal ulcerative colitis, needing further checks.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

The new wound dressing speeds up healing of infected wounds safely and effectively.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

AI improves accuracy and consistency in diagnosing male pattern hair loss.

Abuse of anabolic steroids in Iraqi athletes leads to negative effects on hormones, liver and kidney function, blood sugar, and cholesterol levels.

Researchers found a new ABCD1 gene mutation linked to a rare brain and nerve disorder with unusual brain changes.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

IND-Ca ointment effectively reduces inflammation with minimal skin irritation.

TA-Ado effectively promotes hair growth and reduces hair loss.

AHR ligands could treat inflammatory skin diseases.

A peptide from hair follicle stem cells can boost hair growth.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

KSR1 is crucial for certain skin tumor formation and could be a cancer therapy target.